{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:17:24Z","timestamp":1790338644557,"version":"4.1.0"},"reference-count":38,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Heat-killed<jats:italic>Brucella abortus<\/jats:italic>(HBa) has been proposed as a carrier for therapeutic vaccines for individuals with immunodeficiency, due to its abilities to induce interleukin-2 (IL-2) and gamma interferon (IFN-\u03b3) in both CD4<jats:sup>+<\/jats:sup>and CD8<jats:sup>+<\/jats:sup>T cells and to upregulate antigen-presenting cell functions (including IL-12 production). In the current study, we investigated the ability of HBa or lipopolysaccharide isolated from HBa (LPS-Ba) to elicit \u03b2-chemokines, known to bind to the human immunodeficiency virus type 1 (HIV-1) coreceptor CCR5 and to block viral cell entry. It was found that human peripheral blood mononuclear cells secreted \u03b2-chemokines following stimulation with HBa, and this effect could not be blocked by anti-IFN-\u03b3 neutralizing antibodies. Among purified T cells, macrophage inflammatory protein 1\u03b1 and 1\u03b2 (MIP-1\u03b1 and MIP-1\u03b2, respectively) secretion was observed primarily in human CD8<jats:sup>+<\/jats:sup>T cells. The kinetics of \u03b2-chemokine induction in T cells were slow (3 to 4 days). The majority of \u03b2-chemokine-producing CD8<jats:sup>+<\/jats:sup>T cells also produced IFN-\u03b3 following HBa stimulation, as determined by triple-color intracellular staining. A significant number of CD8<jats:sup>+<\/jats:sup>T cells contained stored MIP-1\u03b2 that was released after HBa stimulation. Both HBa and LPS-Ba stimulated high levels of MIP-1\u03b1 and MIP-1\u03b2 production in elutriated monocytes and even higher levels in macrophages. In these cells, \u03b2-chemokine mRNA was upregulated within 30 min and proteins were secreted within 4 h of stimulation. The monocyte- and macrophage-derived \u03b2-chemokines were sufficient to block CCR5-dependent HIV-1 envelope-mediated cell fusion. These data suggest that, in addition to the ability of HBa to elicit antigen-specific humoral and cellular immune responses, HBa<jats:italic>-<\/jats:italic>conjugated HIV-1 proteins or peptides would also generate innate chemokines with antiviral activity that could limit local viral spread during vaccination in vivo.<\/jats:p>","DOI":"10.1128\/iai.69.6.3817-3826.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:01:19Z","timestamp":1027764079000},"page":"3817-3826","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":18,"title":["Human Peripheral Blood T Cells, Monocytes, and Macrophages Secrete Macrophage Inflammatory Proteins 1\u03b1 and 1\u03b2 following Stimulation with Heat-Inactivated<i>Brucella abortus<\/i>"],"prefix":"10.1128","volume":"69","author":[{"given":"Marina","family":"Zaitseva","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Division of Viral Products1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"King","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Division of Viral Products1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Manischewitz","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Division of Viral Products1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dougan","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Division of Viral Products1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Stevan","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Division of Hematology,2 Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Golding","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Division of Viral Products1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Golding","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Division of Hematology,2 Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.4.1167.004k11_1167_1174"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.5.1722-1729.1993"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1992.8.479"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5243.1811"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5283.1856"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/381661a0"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/381667a0"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5263.872"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.21.11986"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1991.7.435"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.6.3299-3307.1995"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-4613-0357-2_6","article-title":"Design of vaccines for the induction of antibody responses in Th-cell deficient individuals","volume":"282","author":"Golding B.","year":"1995","unstructured":"Golding B. Inman J. Golding H. Design of vaccines for the induction of antibody responses in Th-cell deficient individuals Vaccines: new-generation immunological adjuvants Gregoriades G. 282 1995 51 Plenum Press New York, N.Y","journal-title":"Vaccines: new-generation immunological adjuvants"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(00)01350-2"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-4613-0357-2_7","article-title":"Strategies for the stimulation of CD4\/CD8 T subsets","volume":"282","author":"Golding H.","year":"1995","unstructured":"Golding H. Zaitseva M. Inman J. J. Golding B. Lapham C. Strategies for the stimulation of CD4\/CD8 T subsets Vaccines: new generation immunological adjuvants Gregoriades G. 282 1995 65 Plenum Press New York, N.Y","journal-title":"Vaccines: new generation immunological adjuvants"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.4.1385-1389.1992"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.18.10803"},{"key":"e_1_3_2_18_2","first-page":"251","article-title":"Lipopolysaccharide from an Escherichia coli htrB msbB mutant induces high levels of MIP-1\u03b1 and MIP-1\u03b2 secretion without inducing TNF-\u03b1 and IL-1\u03b2","volume":"1","author":"Hone D. M.","year":"1998","unstructured":"Hone D. M. Powell J. Crowley R. W. Maneval D. Lewis G. K. Lipopolysaccharide from an Escherichia coli htrB msbB mutant induces high levels of MIP-1\u03b1 and MIP-1\u03b2 secretion without inducing TNF-\u03b1 and IL-1\u03b2.J. Hum. Virol.11998251256","journal-title":"J. Hum. Virol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.12.6257-6263.1999"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1196-1240"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/82751"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5287.602"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.5.3084-3092.1996"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0796-767"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1999.tb01338.x"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2000.00993.x"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80110-5"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7779"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.4.507"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.1.876-881.1998"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/382722a0"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.4049\/jimmunol.157.8.3598","article-title":"Synthesis of \u03b2-chemokines MIP-1\u03b1, MIP-1\u03b2, and RANTES is associated with a type I immune response","volume":"157","author":"Schrum S.","year":"1996","unstructured":"Schrum S. Probst P. Fleischer B. Zipfel P. F. Synthesis of \u03b2-chemokines MIP-1\u03b1, MIP-1\u03b2, and RANTES is associated with a type I immune response.J. Immunol.157199635983604","journal-title":"J. Immunol."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1998.14.1263"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.12.2089"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.5.805"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.9.3109"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.7.2720-2728.1995"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.8.3109-3117.1996"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.4.3443-3448.1999"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.6.3817-3826.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.6.3817-3826.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:33:11Z","timestamp":1682263991000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.69.6.3817-3826.2001"}},"subtitle":[],"editor":[{"given":"R. N.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1128\/IAI.69.6.3817-3826.2001"],"URL":"https:\/\/doi.org\/10.1128\/iai.69.6.3817-3826.2001","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]},"assertion":[{"value":"2000-10-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-03-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}